Apyx Medical Corporation (APYX)
1.04
-0.03 (-2.80%)
At close: Apr 15, 2025, 3:59 PM
0.97
-7.27%
After-hours: Apr 15, 2025, 04:21 PM EDT
Apyx Medical Revenue Breakdown
| Period Ending | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Advanced Energy Revenue | 9.29M | 7.45M | 12.13M | 9.84M | 11.72M | 9.69M | 10.54M | 7.08M | 8.36M | 10.81M | 15.03M | 10.31M | 9.98M | 7.66M | 9.88M | 5.48M | 2.87M | 3.99M | 6.94M | 6.09M | 5.27M | 4.37M | 4.34M | 2.98M | 3.11M | 2.63M |
| Advanced Energy Revenue Growth | +24.62% | -38.58% | +23.36% | -16.09% | +20.97% | -8.11% | +48.94% | -15.35% | -22.66% | -28.07% | +45.78% | +3.36% | +30.26% | -22.49% | +80.36% | +91.11% | -28.07% | -42.58% | +13.92% | +15.66% | +20.54% | +0.69% | +45.43% | -4.11% | +18.41% | n/a |
| OEM Revenue | 2.2M | 2.79M | 2.53M | 2.14M | 1.85M | 2.45M | 2.07M | 2.03M | 1.93M | 1.68M | 1.79M | 1.52M | 1.25M | 978K | 1.58M | 1.48M | 1.43M | 1.01M | 1.33M | 1.48M | 1.3M | 1.45M | 1.58M | 687K | 578K | 768K |
| OEM Revenue Growth | -21.21% | +10.40% | +18.13% | +15.86% | -24.67% | +18.68% | +1.57% | +5.50% | +14.83% | -6.20% | +17.92% | +21.83% | +27.40% | -38.18% | +7.25% | +3.22% | +41.35% | -23.81% | -10.40% | +14.01% | -10.54% | -8.39% | +130.71% | +18.86% | -24.74% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 14M | 13.3M | 15.54M | 8.9M | 8.65M | 3.83K | 5.74M | 32.05M |
| Non-Us Revenue Growth | +5.28% | -14.39% | +74.59% | +2.87% | +225892.69% | -99.93% | -82.10% | n/a |
| United States Revenue | 38.34M | 31.21M | 32.98M | 18.81M | 19.58M | 12.86M | 33.15M | n/a |
| United States Revenue Growth | +22.87% | -5.37% | +75.31% | -3.94% | +52.31% | -61.21% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 9.45M | 6.93M | 4.9M | 8.59M | 4.84M | 12.01M | 12.06M | 12.92M | 10.48M | 11.82M | 12.93M | 12.9M | 10.85M | 10.49M | 9.49M | 8.84M | 8.05M | 7.29M | 9.5M | 10.43M | 8.78M | 8.05M | 8.11M | 7.35M | 4.7M | 5.73M | 5.29M | 5.02M | 5.12M | 5.65M | 5.25M | 5.2M | 4.63M | 4.62M | 4.65M | 4.24M | 4.46M | 4.18M | 4.5M |
| Selling, General, and Administrative Revenue Growth | +36.24% | +41.60% | -42.99% | +77.44% | -59.68% | -0.46% | -6.63% | +23.30% | -11.35% | -8.60% | +0.28% | +18.87% | +3.39% | +10.57% | +7.40% | +9.78% | +10.47% | -23.27% | -8.93% | +18.79% | +9.06% | -0.79% | +10.32% | +56.34% | -17.88% | +8.24% | +5.36% | -1.86% | -9.45% | +7.58% | +1.08% | +12.39% | +0.15% | -0.65% | +9.57% | -4.87% | +6.60% | -7.04% | n/a |
| Research and Development Revenue | 1.14M | 1.42M | 1.4M | 1.25M | 1.28M | 1.2M | 1.12M | 1.25M | 1.06M | 1.07M | 1.16M | 947K | 1.18M | 1.08M | 1.11M | 918K | 1.05M | 975K | 980K | 1.1M | 936K | 888K | 810K | 579K | 613K | 816K | 562K | 440K | 610K | 696K | 709K | 676K | 682K | 592K | 668K | 626K | 583K | 505K | 446K |
| Research and Development Revenue Growth | -19.80% | +1.93% | +11.94% | -2.19% | +6.42% | +6.96% | -10.68% | +18.28% | -0.84% | -7.60% | +22.28% | -19.40% | +8.39% | -2.78% | +21.46% | -12.32% | +7.38% | -0.51% | -10.67% | +17.20% | +5.41% | +9.63% | +39.90% | -5.55% | -24.88% | +45.20% | +27.73% | -27.87% | -12.36% | -1.83% | +4.88% | -0.88% | +15.20% | -11.38% | +6.71% | +7.38% | +15.45% | +13.23% | n/a |